Safety and Efficacy of Topical Moxifloxacin for Prevention of Post-Traumatic Endophthalmitis: Randomized Controlled Clinical Trial

Conditions:   Endophthalmitis;   Open Globe Injury;   Moxifloxacin;   Post-Traumatic Endophthalmitis Interventions:   Drug: Moxifloxacin Ophthalmic 0.5% Ophthalmic Solution;   Drug: Ciprofloxacin 400 MG/200 ML Intravenous Solution [CIPRO IV] Sponsor:   University of Campinas, Brazil Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials